Arcellx, Inc. (ACLX)
NASDAQ: ACLX · Real-Time Price · USD
114.83
+0.03 (0.03%)
At close: Apr 10, 2026, 4:00 PM EDT
114.85
+0.02 (0.02%)
After-hours: Apr 10, 2026, 4:47 PM EDT
Arcellx Market Cap
Arcellx has a market cap or net worth of $6.74 billion as of April 10, 2026. Its market cap has increased by 74.90% in one year.
Market Cap
6.74B
Enterprise Value
6.27B
1-Year Change
74.90%
Ranking
Category
Stock Price
$114.83
Market Cap Chart
Since the IPO on February 4, 2022, Arcellx's market cap has increased from $503.15M to $6.74B, an increase of 1,239.03%. That is a compound annual growth rate of 86.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 6.74B | 78.71% |
| Dec 31, 2025 | 3.77B | -9.09% |
| Dec 31, 2024 | 4.15B | 43.89% |
| Dec 29, 2023 | 2.88B | 112.13% |
| Dec 30, 2022 | 1.36B | 170.02% |
| Feb 4, 2022 | 503.15M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Halozyme Therapeutics | 7.75B |
| ImmunityBio | 7.21B |
| Kymera Therapeutics | 7.11B |
| Belite Bio | 7.03B |
| Protagonist Therapeutics | 6.51B |
| Apogee Therapeutics | 6.14B |
| Centessa Pharmaceuticals | 6.11B |
| Terns Pharmaceuticals | 6.08B |